Morgan Garrett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Morgan Garrett has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Audrey Wise
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA
1 shared publication - Brayden Rucker
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK74107, USA
1 shared publication Drew Lestersmith
Baylor Scott & White All Saints Medical Center, Fort Worth, TX 76104, USA
1 shared publication- Kade Ezell
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK74107, USA
1 shared publication - Matt Vassar
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
1 shared publication Mohammed Emam
Department of Physical Medicine & Rehabilitation, The Johns Hopkins University School of Medicine, Baltimore, MD21287, USA
1 shared publication
Latest Publications
- 21 June 2023
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 18 (7) , 531-542
Assessing the Reporting of Harms in Systematic Reviews Focused on Platelet-Rich Plasma Therapy: a Cross-SectionalAnalysis
Aim: Our objectives are: to evaluate the completeness of harms reporting in systematic reviews (SRs) on platelet-rich plasma therapy; to assess the overall methodological quality of the SR using AM... Plain language summary This study looked at how well the negative effects (harms) of platelet-rich plasma therapy are reported in systematic reviews (SRs). The researchers carefully reviewed and ex... Tweetable abstract Harms of platelet rich plasma therapy must be adequately evaluated and reported to provide patients with the best care possible. Of the 103 included systematic reviews, all SRs r...
- 21 June 2023
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 18 (7) , 531-542
Assessing the Reporting of Harms in Systematic Reviews Focused on Platelet-Rich Plasma Therapy: a Cross-SectionalAnalysis
Aim: Our objectives are: to evaluate the completeness of harms reporting in systematic reviews (SRs) on platelet-rich plasma therapy; to assess the overall methodological quality of the SR using AM... Plain language summary This study looked at how well the negative effects (harms) of platelet-rich plasma therapy are reported in systematic reviews (SRs). The researchers carefully reviewed and ex... Tweetable abstract Harms of platelet rich plasma therapy must be adequately evaluated and reported to provide patients with the best care possible. Of the 103 included systematic reviews, all SRs r...